Aptivus OverviewTipranavir (TPV), or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer Ingelheim under the trade name Aptivus AP-ti-vus. It is administered with ritonavir in combination therapy to treat HIV infection. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mutations. ...
Read more Aptivus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tipranavir
Recent Aptivus Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 250mg
- Solution: 100mg/ml, 250mg
NDC Database Records for Aptivus: (2 results)Sorted by National Drug Code
- 0597-0002 Aptivus 100 mg/ml Oral Solution by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0003 Aptivus 250 mg Oral Capsule by Boehringer Ingelheim Pharmaceuticals, Inc.